A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Goodin, Douglas S.
机构：
来源：
NEUROLOGY | 2006年 / 67卷 / 07期
关键词：
D O I：
10.1212/01.wnl.0000243810.20687.51
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1313 / 1313
页数：1
相关论文
共 50 条
  • [41] Clinical characteristics of nonresponders to interferon beta therapy for relapsing-remitting multiple sclerosis
    Waubant, E
    Vukusic, S
    Confavreux, C
    [J]. NEUROLOGY, 2002, 58 (07) : A189 - A190
  • [42] The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil
    Livia Lovato Pires de Lemos
    Augusto Afonso Guerra Júnior
    Marisa Santos
    Carlos Magliano
    Isabela Diniz
    Kathiaja Souza
    Ramon Gonçalves Pereira
    Juliana Alvares
    Brian Godman
    Marion Bennie
    Ivan Ricardo Zimmermann
    Vânia Crisitna Canuto dos Santos
    Clarice Alegre Pretramale
    Francisco de Assis Acurcio
    [J]. PharmacoEconomics, 2018, 36 : 161 - 173
  • [43] Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis
    Zhang, Jian
    Shi, Shengliang
    Zhang, Yueling
    Luo, Jiefeng
    Xiao, Yousheng
    Meng, Lian
    Yang, Xiaobo
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11):
  • [44] Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis
    Etemadifar, Masoud
    Janghorbani, Mohsen
    Shaygannejad, Vahid
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (12) : 1723 - 1728
  • [45] Interferon-β in the treatment of relapsing-remitting multiple sclerosis
    Revel, M
    [J]. PHARMACOLOGY & THERAPEUTICS, 2003, 100 (01) : 49 - 62
  • [46] The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil
    Pires de Lemos, Livia Lovato
    Guerra Junior, Augusto Afonso
    Santos, Marisa
    Magliano, Carlos
    Diniz, Isabela
    Souza, Kathiaja
    Pereira, Ramon Goncalves
    Alvares, Juliana
    Godman, Brian
    Bennie, Marion
    Zimmermann, Ivan Ricardo
    Canuto dos Santos, Vania Crisitna
    Pretramale, Clarice Alegre
    Acurcio, Francisco de Assis
    [J]. PHARMACOECONOMICS, 2018, 36 (02) : 161 - 173
  • [47] Current and future treatments for relapsing-remitting multiple sclerosis
    Birnbaum, Gary
    [J]. CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2010, 13 (02) : 214 - 225
  • [48] Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis
    M. Etemadifar
    M. Janghorbani
    V. Shaygannejad
    [J]. Journal of Neurology, 2007, 254
  • [49] Is interferon effective and safe for relapsing-remitting multiple sclerosis?
    Filippini, G
    Incorvaia, B
    [J]. NEUROEPIDEMIOLOGY, 2002, 21 (06) : 310 - 310
  • [50] No increase of serum autoantibodies during therapy with recombinant human interferon-beta(1a) in relapsing-remitting multiple sclerosis
    Colosimo, C
    Pozzilli, C
    Frontoni, M
    Farina, D
    Koudriavtseva, T
    Gasperini, C
    Salvetti, M
    Valesini, G
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1997, 96 (06): : 372 - 374
12345